Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Pharmaceutical Substance Manufacturing Grant Fund. Establishes the Pharmaceutical Substance Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $34 million per fiscal year and in an aggregate amount not to exceed $191,255,000, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $4 billion and create and maintain at least 500 new full-time jobs. This bill is identical to SB 527.
Introduced
Jan 14, 2026
Last Action
Mar 10, 2026
Session
VA 2026
Sponsors
1 primary · 1 co
Governor's Action Deadline 11:59 p.m., April 13, 2026
Enrolled Bill communicated to Governor on March 10, 2026
Signed by Speaker
Fiscal Impact Statement from Department of Planning and Budget (HB1076)
Bill text as passed House and Senate (HB1076ER)
Signed by President
Enrolled
Passed Senate Block Vote (39-Y 0-N 0-A)
Read third time
Read second time
Rules suspended
Constitutional reading dispensed Block Vote (on 2nd reading) (38-Y 0-N 0-A)
Passed by for the day
Reported from Finance and Appropriations (13-Y 0-N)
Referred to Committee on Finance and Appropriations
Constitutional reading dispensed (on 1st reading)
Read third time and passed House (92-Y 5-N 0-A)
Moved from Uncontested Calendar to Regular Calendar
Read second time and engrossed
Read first time
Reported from Appropriations (21-Y 0-N)
Subcommittee recommends reporting (5-Y 0-N)
Fiscal Impact Statement from Department of Planning and Budget (HB1076)
Assigned HAPP sub: Commerce Agriculture & Natural Resources
Prefiled and ordered printed; Offered 01-14-2026 26102903D
Referred to Committee on Appropriations
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Governor's Action Deadline 11:59 p.m., April 13, 2026
Amy J. Laufer